 Patent Application Title |
Patent App Num. |
Date |
| Continuous preparation method of ginseng ginsenosides and polysaccharides | 20120083592 | 20120405 |
| The present invention provides a continuous preparation method of ginseng ginsenosides and polysaccharides, whereby the ginseng extract liquor and supercritical solvent are poured continuously into a separation tank at 10-30 MPa and 40-60° C. as well as a preset flow rate; so the ginseng extract liquor can be separated in the separation tank to obtain ginsenosides and polysaccharides at different positions of the separation tank.
... |
| Composition with improved bioavailability of saponin and method for improving the bioavailability of saponin (as amended) | 20120076874 | 20120329 |
| The present invention relates to a ginseng mixed composition with improved bioavailability of saponin. Further, the present invention relates to a method for improving saponin bioavailability of a subject comprising: administering to the subject an effective amount of at least one extract selected from a Schizandra chinensis extract and a Liriope platyphylla extract that improves saponin bioavailability in the subject.
... |
| Herbal medicinal composition and extract thereof for inducing proliferation of cranial nerve cells and method of manufacturing the same | 20120076875 | 20120329 |
| A herbal medicinal composition and an extract thereof for inducing proliferation of cranial nerve cells and a method of manufacturing the same are disclosed. The herbal medicinal composition includes Ginseng Radix and Aconiti Tuber.
... |
| Cosmetic or dermatological preparation comprising collagen, chitosan, glycosylaminoglycan and cell growth promoting peptide and/or cellular complex | 20120064182 | 20120315 |
| A cosmetic or dermatological preparation that is obtainable by combining collagen and/or a derivative thereof, chitosan and/or a derivative thereof, glycosylaminoglycan and/or a derivative thereof with a peptide which is capable of promoting skin cell growth and/or with a composition which comprises glycoproteins 1 and 2 and ginseng and horsetail extracts.
... |
| Cosmetic composition containing white ginseng powder | 20120052103 | 20120301 |
| The present invention relates to a cosmetic composition containing white ginseng powder. Applying a cosmetics containing white ginseng powder to the skin of a user stimulates blood circulation and exhibits superior skin scrubbing effect.
... |
Subscribe to updates on this page: Ginseng RSS  |
| Methods for preparing a fermented ginseng concentrate or powder | 20120045428 | 20120223 |
| The present invention relates to a method for preparing a fermented ginseng concentrate. The method first involves subjecting ginseng to an extraction with a solvent to obtain a ginseng extract. Next, pectinase and beta-galactosidase are added to the ginseng extract under conditions effective to ferment the ginseng extract. The fermented extract is then concentrated to produce a fermented ginseng concentrate. The method may further involve drying the fermented ginseng concentrate to obtain fermented ginseng powder. Combinations of the invention ginseng materials with other active and/or inactive materials are also disclosed.
... |
| Application of american ginseng to enhance neurocognitive function | 20120046239 | 20120223 |
| Disclosed are methods of enhancing neurocognitive function by administering of American Ginseng. Preferred dosages in the range of 5 to 50 mg total genosides enhance cognitive function—including, improvement of working memory (WM) performance, attentional performance (e.g., Choice Reaction Time accuracy), and calmness.
... |
| Composition for enhancing immunity containing plant stem cell line derived from cambium of panax ginseng including wild ginseng or ginseng as an active ingredient | 20120039918 | 20120216 |
| The present invention relates to a composition for enhancing immunity, comprising one or more of the following: a homogenous cell line, and a lysate, an extract and a culture medium thereof as an active ingredient. The homogenous cell line, the lysate, the extract and the culture thereof according to the present invention, which are derived from a natural product, minimize adverse side effects of prior immune enhancing agents and safe for the human body. Further, they effectively increase the activity of NK cells responsible for innate immunity, as well as increase the proliferation rate of lymph node cells when the cells were re-exposed to an antigen in a specific immune reaction to enhance acquired immunity, and thus are useful as an immune enhancing agent. In particular,... |
| Compositions and methods for treating hepatitis virus infection | 20120034238 | 20120209 |
| The present invention relates to a method for treating hepatitis virus infection comprising administering to a subject infected with a hepatitis virus an effective amount of a yolk or yolk antibody obtained from an egg of a fowl which has been immunized using Helicobacter pylori as an antigen. In particular, the method is effective in reducing virus titer and/or decreasing a level of glutamic oxaloacetic transaminase (GOT) or glutamic pyruvic transaminase (GPT) in the subject. Also provided is a composition for treating hepatitis virus infection which comprises the yolk or yolk antibody in combination with one or more supplemental ingredients such as Salviae Miltiorrhiza Radix, Oldennlandiae Hb., Zingiberis Radix, Ginseng Radix, Atractylodis Radix, Curcumae Radix, Angelicae Sinensis Radix, bee propolis, calcium lactate, soy proteins, probiotics, and... |
| Food complex for balancing masculine energy and feminine energy and for recovering vital energy | 20110274783 | 20111110 |
| Characterized in that the three kinds of food in the main patent are reduced to two: yin foods with vital energy for the woman and yang foods with vital energy for the man by altering the proportions of foods and adding substances of hot plants, that when drinking them, generate internal heat in the human body, such as ginseng and Yin nature ginger, sulfur and Yang nature reishi mushroom and intermediate nature intermediate staghorn. So as the proposed feeding type is suitable for the treatment of general symptoms of disease in males and females as their constitution and to provide heat to the body in both cases the proportion of cereals is increased up to 70-80 per 100, while that of fruits and vegetables is from... |
| Composition for preventing or treating artherosclerosis | 20110268824 | 20111103 |
| A composition according to the present invention is a composition containing extract of Panax ginseng C.A. Meyer fruit as an active ingredient for preventing or treating artherosclerosis. The extract is confirmed to effectively suppress lesions or generation of a vascular inflammation factor caused by artherosclerosis. Thus, the composition is suitable for use as an active ingredient of the composition for preventing or treating artherosclerosis.
... |
| Method for preparing extract fracton reinforced with ginsenosides rg1 or rb1 from ginseng | 20110268823 | 20111103 |
| The present invention provides a method for preparing an extract fraction reinforced with ginsenoside Rg1 or Rb1 from ginseng. The method for preparing an extract fraction reinforced with ginsenoside Rg1 comprises the steps of: concentrating an alcohol extract of ginseng and then adsorbing the extract diluted in water by adding the extract to an adsorption resin; passing distilled water through the adsorption resin, then eluting and removing unadsorbed ingredients; and adding 30 to 40 v/v % alcohol to the adsorption resin to obtain an eluate. The method for preparing an extract fraction reinforced with ginsenoside Rb1 comprises the steps of: concentrating an alcohol extract of ginseng and then adsorbing the extract diluted in water by adding the extract to an adsorption resin; passing distilled water through... |
| Topical skin care composition | 20110229538 | 20110922 |
| Topical skin care compositions containing a combination of ascorbic acid or a derivative thereof, brown algae extract, and a blend of botanical extracts comprising cucumber extract, watercress extract, birch leaf extract, red clover extract, and St. John's wort extract, and, optionally, ginseng extract, as well as methods of using the same, are disclosed.
... |
Subscribe to updates on this page: Ginseng RSS |
| Composition for cancer prevention or treatment containing as active ingredient plant stem cell line dervied from cambium of panax ginseng including wild ginseng or ginseng | 20110229443 | 20110922 |
| The cell line according to the present invention, a lysate thereof, an extract thereof and a culture medium thereof are derived from a natural and have minimized side effects compared to the conventional therapeutic drugs, and thus are safe for the human body. Also, they are involved directly in the growth of cancer to induce cancer cell death effectively, and show anticancer activity of inhibiting or reducing the formation of tumor or the growth of tumor, Accordingly, the cell line, the lysate thereof, the extract thereof and the culture medium thereof are useful for the prevention, treatment and alleviation of cancer.
... |
| Composition for preventing or treating aids containing plant stem cell line derived from cambium of panax ginseng including wild ginseng or ginseng as active ingredient | 20110217273 | 20110908 |
| The present invention relates to a composition for preventing or treating acquired immunodeficiency syndrome (AIDS), comprising one or more of the following: a homogenous cell line, and a lysate, an extract and a culture thereof as an active ingredient. The homogenous cell line, the lysate, the extract and the culture thereof, which are derived from a natural product, minimize adverse side effects of prior therapeutic agents and safe for the human body. Further, they effectively increase the count of T cells such as CD4+ T cells and decrease the number of HIVs, thereby preventing opportunistic infection, dysneuria, and neoplasia caused by immune incompetence, and ultimately the risk of death. Therefore, they are useful in preventing and treating AIDS, and relieving symptoms of AIDS.
... |
| Ingestibles containing sugar and cinnamon or ginseng | 20110212192 | 20110901 |
| A composition of ingestible ingredients containing a first ingestible ingredient which has an undesired effect on the human body when ingested, wherein preferably the ingredient is sugar and the undesired effect is blood sugar fluctuations which can lead to diabetes, and at least one other ingestible ingredient which reduces the impact or the undesired effect of the first ingestible ingredient, wherein the other ingredient is either cinnamon or polyphenols from cinnamon, or ginseng or ginsenosides from ginseng. The composition may be in a package, a bulk mix or a product.
... |
| Composition for the maintenance of blood sugar levels comprising cinnamon and ginseng | 20110212191 | 20110901 |
| A composition is disclosed which comprises cinnamon or cinnamon extract such as cinnamon aqueous extract TC 112 and panax ginseng or extract from panax ginseng standardized to 1.5 to 7% ginsenosides and may comprise an artificial sweetener. The composition is embodied in the form of a pill or food product with 120 mg of cinnamon aqueous extract and 120 mg of ginseng standardized to 1 5 to 7% ginsenosides. The composition is used as a daily dosage for improvement of cognitive function, prevention or treatment of Alzheimer's disease, maintenance or lowering of blood-sugar levels, prevention of arterial disease or the improvement of cognitive function in diabetics.
... |
| Lifeforce liquid supplement | 20110189319 | 20110804 |
| Two very important factors in human life—which play vital roles in promoting well being—includes returning the body to homeostasis and giving boost to body called lifeforce to get overall health free from diseases, i.e., its optimal balanced functioning ability. When the body is at homeostasis, there is no place for disease. It is only when the body is out of balance (something is deficient, in excess or stagnating) that pain, illness or disease can occur. The application described is based on returning the body to homeostasis (removing the problem and balancing the body) by providing lifeforce and not on dealing with the symptom (e.g., pain, vitamin deficiency). Imbalance results in various diseases and adverse health conditions (starting from aging to diabetes and cancers). This wonderful composition... |
| Composition and method for increasing post workout recovery | 20110144044 | 20110616 |
| The composition of a dietary supplement is provided for increasing post workout recovery, increasing replenishment and regaining energy following exercise. A method for achieving the same is also provided. The present composition comprises branched chain amino acids, caffeine and a source of carbohydrates including waxy maize. The dietary supplement may further comprise one or more of Ginseng providing ginsenoside saponins, and Fenugreek seeds providing 4-Hydroxyisoleucine.
... |
| Anti-aging or antioxidant composition containing plant stem cell line derived from cambium of panax ginseng | 20110097310 | 20110428 |
| The present invention relates to an anti-aging or antioxidant composition which contains, as an active ingredient, a plant stem cell line derived from the cambium of Panax ginseng, including wild ginseng and ginseng, or an extract thereof, a lysate thereof and a culture thereof. The composition has minimized side effects compared to existing anti-aging agents and antioxidants, and thus is safe for the skin. Also, the composition of the present invention shows an antioxidant effect of inhibiting reactive oxygen species caused by exposure to UV radiation that is the major cause of skin aging, and it can effectively reduce or inhibit aging-related factors. Thus, the composition is useful for the prevention and inhibition of aging.
... |
| Lymphatic vessel stabilizer | 20110091584 | 20110421 |
| Provided is a lymphatic vessel stabilizer composed of Tie2 activator. The Tie2 activator is preferably at least one type selected from the group consisting of angiopoietin 1 (Ang-1), extract of Cinnamomum species plants, extract of Siberian Ginseng and syringaresinol.
... |
| Activation of innate and adaptive immune responses by a ginseng extract | 20110086052 | 20110414 |
| The invention is directed to ginseng fractions and methods for activating innate and adaptive immune responses to prevent, treat or ameliorate a condition in a subject by administering to the subject an effective amount of a ginseng traction, a pharmaceutical composition comprising the fraction in combination with another medicament or with one or more pharmaceutically acceptable carriers, or a food item comprising the fraction. The fraction may be made from Panax quinquefolius' or may be selected from CVT-E002, PQ2, PQ223 and purified fractions from CVT-E002, PQ2 and PQ223.
... |
| External preparation composition for skin comprising ginseng flower or ginseng seed extracts | 20110085996 | 20110414 |
| Provided are a use of a ginseng flower extract and a use of a ginseng seed extract. The ginseng seed extract includes ginseng seed oil or a ginseng seed residue extract. The uses include skin protection, anti-aging, anti-wrinkle, improvement of skin elasticity, skin whitening, skin moisturizing, prevention and improvement of skin dryness diseases such as atopy, removal of the horny layer, sebum control, anti-inflammation, prevention or improvement of skin troubles such as acne, improvement of skin complexion, prevention of hair loss, anti-dandruff, improvement of gloss and softness of hair, improvement of volume and elasticity of face or body, and improvement of facial or body line.
... |
| Biodegradable thermoresponsive 3-arm polyethylene glycol poly(lactide-co-glycolide) copolymer for ginseng administration | 20110070320 | 20110324 |
| The present invention discloses a composition comprising a ginseng product, a mucoadhesive and a mucosa penetration enhancer in an aqueous biodegradable block copolymer solution consisting of a 3-arm polyethylene glycol (PEG) and 3 polyesters chains, each of which extends on each of the arm of the 3-arm PEG. The invention also provides a method for transmucosal delivery of pharmaceuticals and nutraceutical such as ginsenosides with improved absorption and bioavailability.
... |
| Composition comprising polysaccharide extracted from panax ginseng preventing and treating liver diseases | 20110046086 | 20110224 |
| The present disclosure relates to a Panax ginseng polysaccharide extract, which is useful for liver protection or for the prevention and treatment of liver diseases, and a method for preparing the same. Further, the present invention relates to a composition for the prevention and treatment of liver diseases, comprising the Panax ginseng polysaccharide extract as an active ingredient, and a food composition comprising the same.
... |
| Plant extracts as additives for yeast raised baked goods | 20110045129 | 20110224 |
| The present invention relates to the use of an active component for improving dough stability of yeast dough, for making baked goods, and/or for improving the volume of yeast raised baked goods, wherein the active component comprises a member selected from the group consisting of an extract of any part of a plant of the species ginseng (Panax ginseng C. A. Meyer), an extract of any part of a plant of the species notoginseng (Panax pseudoginseng), an extract of any part of a plant of the species washnut (Sapindus mucorossi), an extract of any part of a plant of the species butcher's broom (Ruscus aculeatus), an extract of any part of a plant of the genus yucca, an extract of any part of a plant of... |
| Compartment-specific plant extract combination of ginkgo biloba extract and ginseng extract having a tandem effect | 20110034563 | 20110210 |
| The invention relates to a plant extract combination of ginkgo and ginseng which is effective especially in a (synergistic) over-additive manner and optionally comprises whitethorn extract. Ginseng is used in the form of an ethanol/ethanol/water extract while ginkgo is used in the form of an acetone/acetone-water extract, for example, and the active extracts are prepared at specific quantitative ratios, particularly <1.1:1, thus unexpectedly boosting the prevention or also the treatment of a decline in the mental capacity related to age or also other disorders. This results from an over-additive tandem effect by protecting neural cells and improving blood circulation while increasing energy supply and activating cerebral metabolism, not only in the cognitive-therapeutic field, an effect being obtained against harmful oxidative influences caused especially by decomposition products... |
| Composition comprising an extract of herbal combination thereof for preventing and treating diabetes mellitus | 20110027305 | 20110203 |
| Provided is a composition for treating and preventing diabetes or diabetic complications comprising an extract of herbal combination as an effective ingredient. The composition for treating and preventing diabetes or diabetic complications includes an extract of herbal combination of bitter melon, caterpillar fungus, wolfberry tree bark, white mulberry bark, winged euonymus, kudzu root, Solomon's seal, white atractylodes rhizome, mondo grass rhizome, Japanese cornel fruit and ginseng as an effective ingredient. The composition increases secretion of insulin in a type 2 diabetic animal, improves insulin resistance and exhibits potent blood sugar-lowering and diabetic complication inhibiting activities. Further, since it is safe with natural product ingredients, it may be usefully used to prevent and improve diabetic diseases and inhibit diabetic complications.
... |
| Composition for treatment of hyperhidrosis | 20110020415 | 20110127 |
| A composition for treatment of hyperhidrosis is provided that contains an effective amount of an antiperspirant. In particular, one embodiment of the composition of the present invention includes an antiperspirant, at least one muscle relaxing agent, at least one peptide, and at least one botanical agent and the composition is applied to a substrate. In another non-limiting illustration, the composition includes from about 0.001 to 50.0 vol % aluminum zirconium tetrachlorohydrex glycine and more preferably 19.0 vol %, glycerin, dipeptide diaminobutyroyl benzylamide diacetate, gamma amino butyric acid, solanum lycopersicum (tomato) extract, gynostemma pentaphyllum extract, panax ginseng root extract, portulaca oleracea extract, butylene glycol, denatured alcohol, and water.
... |
| Pharmaceutical composition | 20100330205 | 20101230 |
| A pharmaceutical composition comprising 1.5 parts by weight powdered fennel, 2.0 parts by weight powdered rhubarb, 1.0 part by weight powdered glycyrrhiza, 2.0 parts by weight powdered phellodendron bark, 1.0 part by weight powdered zedoary, 1.5 parts by weight powdered picrasma wood, 1.0 part by weight powdered matricaria chamomilla, 1.5 parts by weight powdered geranium herb, 1.0 part by weight powdered ginseng, 1.5 parts by weight powdered citrus unshiu peel, 1.0 part by weight powdered scutellaria root, 1.0 part by weight powdered magnolia bark, 2.0 parts by weight powdered oyster shell, 1.0 part by weight powdered cyperus rhizome, 2.0 parts by weight powdered platycodon root, 2.0 parts by weight powdered melia azedarach, 1.0 part by weight powdered cnidium rhizome, 2.0 parts by weight sodium bicarbonate and... |
| Pharmaceutical compositions with a mechanism of multi-target receptor retroaction for treating depression | 20100311674 | 20101209 |
| Oral pharmaceutical compositions or functional foods with a mechanism of multi-target receptor retroaction for treating depression comprising ginseng saponin (Rg1+Rb1), glycyrrhizic acid and jujuba cAMP. Experiments demonstrate that as compared with the preferred drug for treating depression Paroxetine in the art, the present invention has significant anti-depression efficacy.
... |
| Pharmaceutical compositions for treating anxiety | 20100310682 | 20101209 |
| Pharmaceutical compositions or functional foods for treating anxiety comprising ginseng saponin (Rg1+Rb1), glycyrrhizic acid and jujuba cAMP. Experiments demonstrate that as compared with the preferred drug for treating diazepam in the art, the present invention has significant anxielytic efficacy.
... |
| Pharmaceutical compositions for treating depression and anxiety | 20100310683 | 20101209 |
| Pharmaceutical compositions or functional foods for treating depression and anxiety comprising ginseng saponin (Rg1+Rb1), glycyrrhizic acid and jujuba cAMP. Experiments demonstrate that as compared with the preferred drug for treating depression and anxiety paroxetine and diazepam in the art, the present invention has significant anti-depression and anxielytic efficacy.
... |
| Use of melanin biosynthesis inhibitors from korean ginseng and the cosmetic composition containing thereof for skin whitening | 20100310485 | 20101209 |
| Disclosed herein is a whitening cosmetic composition containing plant-derived ginsenoside Fl (20-O-β-D-glucopyranosyl-20(S)-protopanaxatriol) as an active ingredient. More specifically, the ginsenoside Fl is obtained from particularly a ginseng extract using an acid, a base, an enzyme or microorganism, and a whitening cosmetic composition containing the ginsenoside Fl has an excellent effect of inhibiting melanin biosynthesis, and thus provides an excellent skin whitening effect.
... |
| Composition for treatment of ischemic heart disease, facilitation of blood circulation and angiogenesis, improving skin beauty, improving male sexual function containing ginseng berry extract | 20100297270 | 20101125 |
| A composition containing ginseng berry extract as active ingredient is for facilitation of blood circulation, for prevention of vascular aging, for treatment of vascular inflammation, for facilitation of angiogenesis, for treatment of ischemic heart disease, for improvement and treatment of local blood circulation insufficiency, for improvement of skin beauty and for improvement of male sexual function. More particularly, the compositions containing ginseng berry extract as active ingredient facilitate nitric oxide (NO) generation in endothelial cells, improve viability of endothelial cells, and facilitate angiogenesis through increased mobility of endothelial cells and vascular tube formation; provide antioxidative effect, facilitate biosynthesis of collagen, provide skin aging inhibiting and wrinkle improving effects through inhibition of MMP-1, provide skin whitening effect through inhibition of melanin synthesis, and provide skin moisturizing effect;... |
| Diet food using pork skin | 20100291281 | 20101118 |
| A process for making a diet food product, includes the stage of putting a certain amount of treated pork skin into an s-cutter and pouring in boiled water with 100:400 ratio, then by opening the steam valve and applying steam into the pot for 20-30 minute then, in order to reduce a fat portion, pour the water and apply the steam again for 30˜60 minute with cover closed, then the temperature and the pressure increase and collected at the bottom of the pot, cutting the boiled pork skin, applying 0.67% of salt to produce a gel and making a gel that is sticky, to eliminate the smell, add ginger, garlic, ginseng, soju and then fix the form.
... |
| Methods for preparing a fermented ginseng concentrate or powder | 20100291244 | 20101118 |
| The present invention relates to a method for preparing a fermented ginseng concentrate. The method first involves subjecting ginseng to an extraction with a solvent to obtain a ginseng extract. Next, pectinase and beta-galactosidase are added to the ginseng extract under conditions effective to ferment the ginseng extract. The fermented extract is then concentrated to produce a fermented ginseng concentrate. The method may further involve drying the fermented ginseng concentrate to obtain fermented ginseng powder.
... |
| Processes of making north american ginseng fractions, products containing them, and use as immunomodulators | 20100278945 | 20101104 |
| The invention is directed to chemical processes of preparing fractions from North American Ginseng (Panax quinquefolium) and pharmaceutical compositions containing these fractions. The products of the present invention may be used to stimulate the production of cytokines and/or antibodies, or as therapeutics targeted at conditions characterized by low immunity, such as the common cold, influenza, chronic fatigue syndrome, AIDS and cancer.
... |
| Application of american ginseng to enhance neurocognitive function | 20100278944 | 20101104 |
| Disclosed are methods of enhancing neurocognitive function by administering of American Ginseng. Preferred dosages in the range of 5 to 50 mg total genosides enhance cognitive function—including, improvement of working memory (WM) performance, attentional performance (e.g., Choice Reaction Time accuracy), and calmness.
... |
| Uses of north american ginseng fractions for treating leukemia | 20100260871 | 20101014 |
| The invention is directed to a method of treating hematological malignancies by administering to the subject ginseng fractions from North American ginseng (Panax quinquefolium). The present invention can be used to activate the proliferation of hemopoietic cells in a patient in need of treatment, or as a therapeutic targeted at conditions characterized by hematological malignancy, such as an abnormal proliferation of blood cells, lymphocytes, multiple myeloma, etc. The invention also includes a method of treating leukemia by activating the proliferation of natural killer (NK) cells and monocytes in the bone marrow and the spleen of the patient by administering at least one ginseng fraction selected from the group consisting of CVT-E002, PQ2, PQ223 and purified fractions from CVT-E002, PQ2 and PQ223. The present invention may be... |
| Use of ginseng fractions for preventing or reducing hematological malignancies | 20100221365 | 20100902 |
| The invention is directed to ginseng fractions, methods of preventing or reducing hematological malignancies such as leukemia, and methods of elevating NK cells in a subject by administering to the subject an effective amount of a ginseng fraction, a pharmaceutical composition comprising the fraction in combination with another medicament or with one or more pharmaceutically acceptable carriers including food items. The fraction may be made from Panax quinquefolius or may be selected from CVT-E002, PQ2, PQ223 and purified fractions from CVT-E002, PQ2 and PQ223.
... |
| Herbal mixture extract of pleurotus eryngii, acanthopanacis cortex and notoginseng radix and a composition comprising the same for prevention and treatment of periodontitis | 20100196288 | 20100805 |
| The present invention relates to a herbal mixture extract of Pleurotus eryngii, Acanthopanacis Cortex and Notoginseng Radix and a composition for prevention and treatment of periodontal disease containing the herbal mixture extract as an active ingredient, more precisely, a herbal mixture extract having activities of inhibiting the generation and activation of osteoclasts by enhancing the expression of osteoprotegerin (OPG) in osteoblasts, preventing alveolar bone from destruction by inhibiting the proliferation of osteoclasts and maintaining the growth of periodontal ligament cells and gingival fibroblasts, and a composition for prevention and treatment of periodontal disease containing the above mixture as an active ingredient.
... |
| Composition of skin external application containing ginseng berry extracts | 20100189821 | 20100729 |
| Disclosed herein is a. skin external composition containing ginseng berry extract. More specifically, disclosed is a skin external composition, which contains, as an active ingredient, ginseng berry extract having the specific components and compositions, among the above-ground parts of ginseng, and thus promotes the production of collagen in the skin, shows an MMP-I inhibitory effect and, at the same time, has skin-aging inhibitory and wrinkle-reducing effects, resulting from antioxidant effects and DNA damage-protecting effects. Also disclosed is a skin external composition, which contains, as an active ingredient, ginseng berry extract, which has a skin whitening effect resulting from the effects of inhibiting melanin production and reducing pigmentation caused by UV radiation, the effects of relieving dry skin symptoms and atopic symptoms by inducing and maintaining the... |
| Medical herb composition for inhibiting shedding of a mammal's hair and method for preparing the same | 20100173023 | 20100708 |
| The present invention relates to a medical herb composition for reducing shedding of mammal hair and a method for preparing the same. The medical herb composition comprises: a first herb material selected from the group consisting of Ginseng Radix, Astragali Radix, Batatatis Rhizoma, Zizyphi Fructus, Tremella, Codonopsis Pilosula, or the combination thereof; a second herb material selected from the group consisting of Angelicae Radix, Rehmanniae Preparata Radix, Longanae Arillus, Lycii Fructus, Paeonia lactiflora, or the combination thereof; and a third herb material selected from the group consisting of Rehmanniae Radix, Ligustrum Lucidum, Eclipta prostrata, Dendrobium hancockii, Polygonum multiflorun (i.e. Dioscorea bulbifera or Cynanchum wilfordi), or the combination thereof. The medical herb composition of the present invention can reduce shedding of mammal hair, promote the growth of... |
| Composition for heart disease, its active ingredients, method to prepare same and uses thereof | 20100136146 | 20100603 |
| This invention provides a composition for heart disease comprising extracts from raw herbs of 80.0-97.0% Radix Salviae Miltorrhizae, 1.0-19.0% Panax Notoginseng and 0.1-1.0% Borneol and its active ingredients. This invention also provides a method for preparing said composition and the active ingredients of the composition. Finally, this invention provides various uses of said compositions and the active ingredients.
... |
| Composition comprising rehmanniae radix preparata, notoginseng radix or mixture extract thereof for preventing and treating of periodontitis as an effective component | 20100129476 | 20100527 |
| Disclosed is a pharmaceutical composition for the treatment and prevention of periodontal diseases, comprising an extract from Rehmanniae Radix Preparata, Panax notoginseng (Burk.) F. H. Chen or a mixture thereof as an active ingredient. Having the activity of protecting the alveolar bone and promoting the proliferation of periodontal ligament cells as well as inhibiting the release of TNF-α, the extract can be applied to the preparation of a pharmaceutical composition or a health food composition useful in the treatment and prevention of periodontal diseases.
... |
| Pharmaceutical composition comprising fermented ginseng | 20100081639 | 20100401 |
| A process for preparing a processed ginseng extract with enhanced pharmacological effects due to subsequent treatment is disclosed. The subsequent treatment includes an acid-treatment of ginseng and a bio-converting treatment, such as a lactic acid bacterial fermenting and an intestinal bacterial fermenting process.
... |
| Composition comprising the extract of crude drug complex having neuroprotective activity for preventing and treating stroke and neurodegenerative diseases | 20100055213 | 20100304 |
| The present invention relates to a composition comprising an extract of crude drug complex comprising Panax ginseng C. A. Meyer, Acanthopanax senticosus HARMS, Angelica sinensis DIELS, Scutellaria baicalensis GEORGI, prevention and treatment of stroke and neurodegenerative diseases such apoplexy, Alzheimer's disease (AD), Parkinson's disease (PD), Pick's disease, Creutzfeldt-Jakob disease and senile dementia.
... |
| Cosmetic composition comprising tissue cultured panax ginseng c.a. meyeradventitious root itself and a preparing method thereof | 20100055212 | 20100304 |
| The present invention relates to a cosmetic composition comprising tissue-cultured adventitious roots itself of ginseng, and to a preparing method thereof. The cosmetic composition of the present invention is characterized in that effective ingredients are dip-extracted from the tissue cultured adventitious roots of a ginseng contained in the composition, without any additional process for preparing an extract of the tissue-cultured adventitious roots of a ginseng. In the cosmetic composition of the present invention, the effective ingredients are naturally and continuously dip-extracted from the tissue-cultured adventitious roots itself of a ginseng and maintained, and also allows a user to recognize visually the presence of the adventitious roots of a ginseng, thereby giving trust of the presence of the effective ingredient to the user, and improving user's satisfaction... |
| health beverage and additive mixture for preparing the same | 20100040757 | 20100218 |
| A beverage includes a liquid base, a coffee component, a saccharide component, a ginseng component, and a protein component. Per 8 ounces of the liquid base, the coffee component comprises between about 0.75 grams to about 12.65 grams, the saccharide component comprises between about 2.4 grams to about 23 grams, the ginseng component comprises between about 0.1 grams to about 0.6 grams, and the protein component comprises between about 1.24 grams to about 42.745 grams.
... |
| Herbal composition | 20100040708 | 20100218 |
| An herbal composition for treating menopausal symptoms in a woman includes yarrow, damiana, skullcap, chaste tree berry, wild yam, corn silk, cramp bark, bloodroot, fenugreek, feverfew, cardamom, and panax ginseng. The herbal composition may either be in a liquid dosage form or in a solid dosage form. Further disclosed is a method for treating menopausal symptoms in a woman using the aforementioned herbal composition. The method includes orally administering the herbal composition, one to two times per day, to the woman.
... |
| Composition comprising ginsenosides isolated from the extract of processed ginseng for preventing and treating thrombotic disease | 20100028467 | 20100204 |
| The present invention relates to compositions containing an extract of processed Panax genus plant and ginsenosides isolated therefrom for treat thrombotic diseases in human or mammal, the method for treating said diseases using thereby and the use thereof.
... |
| Ginseng wine | 20100009058 | 20100114 |
| The present application discloses a process for making ginseng wine.
... |
| Second run ginseng wine | 20100009029 | 20100114 |
| The present application discloses a process for making second run ginseng wine.
... |
| Compositions and methods for promoting brain and cardiovascular health, preventing and treating brain and cardiovascular disorders | 20090317497 | 20091224 |
| Compositions, kits and methods are provided for promoting brain and cardiovascular health, preventing or treating neurological and vascular disorders. In one embodiment, the composition comprises Rhodiola rosea (root), Ginkgo biloba (leaf), Panax notoginseng (root), and Ligusticum chuanxiong (rhizome). The composition can be used as pharmaceuticals or nutraceuticals for promoting general brain health, maintaining a healthy brain, and all neurological disorders such as memory loss, ischemic stroke, neurodegenerative diseases (e.g., Huntington's disease, Alzheimers's disease, and amyotrophic lateral sclerosis) and vascular diseases such as arteriosclerosis, congestive heart failure, hypertension, cardiovascular diseases, cerebrovascular diseases, renovascular diseases, mesenteric vascular diseases, pulmonary vascular diseases, ocular vascular diseases, peripheral vascular diseases, peripheral ischemic diseases, and the like.
... |
| Herbal composition for skin care | 20090291156 | 20091126 |
| The present invention also provides a method for improving aging skin of a subject, comprising administrating a composition comprising extract of Panax ginseng, Acanthopanax and Carthamus tinctorius to the subject.
... |
| pharmaceutical composition for the treatment and/or prevention of hyperlipidemia, processes for producing the same and the use thereof | 20090291154 | 20091126 |
| The present invention discloses a pharmaceutical composition comprising Polygonum multiflorum Thunb, which comprises Polygonum multiflorum Thunb, Fructus Crataegi, Salvia miltiorrhiza Bunge and Radix Notoginseng. If needed, the pharmaceutical composition may comprise the pharmaceutically acceptable carriers. The weight ratio of Polygonum multiflorum Thunb, Salvia miltiorrhiza Bunge, Fructus Crataegi and Radix Notoginseng in the present composition is as follows: 10 to 20 parts of Polygonum multiflorum Thunb, 5 to 15 parts of Salvia miltiorrhiza Bunge, 10 to 20 parts of Fructus Crataegi and 1 to 10 parts of Radix Notoginseng. Also, the present invention discloses the methods for preparing the composition, including directly pulverizing the medicines into powder to produce the composition or preparing the medicines into the extracts and then make the extracts into drugs. The composition... |
| Method and system for inducing anti-aging in skin | 20090281048 | 20091112 |
| A method of treating the skin and accelerating its natural anti-aging and wound-healing processes by using photorejuvenation at a specified total light flux at a specified range of wavelengths from a hand-held light source in combination with the topical ingredients including extracts. Some extracts may be panax ginseng, camellia sinensis, and/or gynostemma pentaphyllum, to effect superior transdermal penetration and intra-cellular delivery, effecting greater bioavailability and bioutilization of some other anti-aging topicals.
... |
| Method and system for inducing anti-aging in skin | 20090281048 | 20091112 |
| A method of treating the skin and accelerating its natural anti-aging and wound-healing processes by using photorejuvenation at a specified total light flux at a specified range of wavelengths from a hand-held light source in combination with the topical ingredients including extracts. Some extracts may be panax ginseng, camellia sinensis, and/or gynostemma pentaphyllum, to effect superior transdermal penetration and intra-cellular delivery, effecting greater bioavailability and bioutilization of some other anti-aging topicals.
... |
| Menopause treatment composition and regimen | 20090274780 | 20091105 |
| Disclosed are compositions and methods for treating symptoms associated with menopause and/or perimenopause. The compositions are based on a combination of concentrated extracts containing black cohosh, ginseng, red clover, soy isoflavones and St. John's wort, in the form of active compounds of these extracts. The treatment regimen, entail orally administering to a human subject suffering from symptoms of menopause and/or perimenopause, an effective dosage in effective amounts of the noted composition.
... |
| Menopause treatment composition and regimen | 20090274780 | 20091105 |
| Disclosed are compositions and methods for treating symptoms associated with menopause and/or perimenopause. The compositions are based on a combination of concentrated extracts containing black cohosh, ginseng, red clover, soy isoflavones and St. John's wort, in the form of active compounds of these extracts. The treatment regimen, entail orally administering to a human subject suffering from symptoms of menopause and/or perimenopause, an effective dosage in effective amounts of the noted composition.
... |
| Edible product containing ginseng polysaccharides and beneficial bacteria | 20090269307 | 20091029 |
| One aspect of the present invention relates to an edible product containing: • probiotic bacteria in an amount of at least 103 bacteria per gram; and • at least 0.5 mg/g of ginseng polysaccharides containing at least 2 monosaccharide units, preferably at least 4 monosaccharide units. Another aspect of the invention relates to the use of the aforementioned product in therapeutic and prophylactic treatments. The present invention further provides a method of producing a packaged liquid edible product containing probiotic bacteria and ginseng polysaccharides in the aforementioned amounts.
... |
| Edible product containing ginseng polysaccharides and beneficial bacteria | 20090269307 | 20091029 |
| One aspect of the present invention relates to an edible product containing: • probiotic bacteria in an amount of at least 103 bacteria per gram; and • at least 0.5 mg/g of ginseng polysaccharides containing at least 2 monosaccharide units, preferably at least 4 monosaccharide units. Another aspect of the invention relates to the use of the aforementioned product in therapeutic and prophylactic treatments. The present invention further provides a method of producing a packaged liquid edible product containing probiotic bacteria and ginseng polysaccharides in the aforementioned amounts.
... |
| Composition and method for treating bedsores, cuts and burns | 20090263500 | 20091022 |
| The invention provides a composition and method to prevent and treat bedsores rapidly, efficaciously and economically. The composition comprises a novel combination of herbal extracts that has surprisingly synergistic and highly efficacious effects for the acceleration of wound healing, and which also disinfects and relieves pain in dermal wounds. The composition can also be used for the rapid healing of dermal burns and dermal cuts. The composition is comprised of extracts of aloe vera, passion flower, goldenseal, and American ginseng, and optionally includes ionic silver and mimosa extract. The treatment method comprises administering a fluid and or gel form of the composition to the wounded skin and or wound cavity therein as a prophylactic or therapeutic dose, and may be delivered by means of a wound... |
| Chinese medicine composition and preparation method and use thereof | 20090238902 | 20090924 |
| This invention relates a traditional Chinese medicine composition and the drug containing this composition as well as preparation method and use thereof. The composition comprises 1-10 parts by weight of radix ginseng, 1-10 parts by weight of folium ginkgo, 0.05-0.5 parts by weight of stigma croci and 5-10 parts by weight of glycine max l. merrill. The components can be the traditional Chinese medicinal materials or the extracts obtained by extracting the same quantity of the Chinese medicinal material. The Chinese medicine composition can be used for the treatment of ischemic cerebrovascular disease and senile dementia.
... |
| Pharmaceutical composition for treating depression and method for preparation thereof | 20090232914 | 20090917 |
| A pharmaceutical composition for treating depression and method for preparation thereof is provided. The pharmaceutical composition includes Radix Ginseng, Radix Glycyrrhizae, and/or their aqueous or alcoholic extract. Fructus Jujubae or their aqueous or alcoholic extract can also be included in the pharmaceutical composition.
... |
| Pharmaceutical composition for treating depression and method for preparation thereof | 20090232914 | 20090917 |
| A pharmaceutical composition for treating depression and method for preparation thereof is provided. The pharmaceutical composition includes Radix Ginseng, Radix Glycyrrhizae, and/or their aqueous or alcoholic extract. Fructus Jujubae or their aqueous or alcoholic extract can also be included in the pharmaceutical composition.
... |
| Medical herb composition for the alleviation of cardiopulmonary ailments or the improvement of cardiopulmonary function in a mammal | 20090208596 | 20090820 |
| A medical herb composition for the alleviation of cardiopulmonary ailments or the improvement of cardiopulmonary function in a mammal is disclosed. The medical herb composition comprises: Schisandra extract; Ginseng extract; Radix ophiopogonis extract; and Saliva miltiorrhiza extract. The medical herb composition comprising the extracts above is proved to be efficient in enhancing cardiopulmonary function of a mammalian patient without heart disease, enforcing energy and raising strength. The medical herb composition is also capable of reducing the symptoms of breathing difficulties and stagnation of vital energy.
... |
| Medical herb composition for the alleviation of cardiopulmonary ailments or the improvement of cardiopulmonary function in a mammal | 20090208596 | 20090820 |
| A medical herb composition for the alleviation of cardiopulmonary ailments or the improvement of cardiopulmonary function in a mammal is disclosed. The medical herb composition comprises: Schisandra extract; Ginseng extract; Radix ophiopogonis extract; and Saliva miltiorrhiza extract. The medical herb composition comprising the extracts above is proved to be efficient in enhancing cardiopulmonary function of a mammalian patient without heart disease, enforcing energy and raising strength. The medical herb composition is also capable of reducing the symptoms of breathing difficulties and stagnation of vital energy.
... |
| Energy drink compositions | 20090186127 | 20090723 |
| A composition that may be mixed with a fluid comprises a vitamin B, vitamin C, taurine, an extract of ginkgo biloba, and an extract of guarana. The composition may further comprise one or more of caffeine, an extract of ginseng, excipients, sweeteners, effervescents, salts, lubricants, preservatives, flavorants and colorants. The composition may be dissolved in water or other liquid for consumption.
... |
| Health beverage and additive mixture for preparing the same | 20090186144 | 20090723 |
| A beverage includes a liquid base, a coffee component, a saccharide component, a ginseng component, and a protein component. Per 8 ounces of the liquid base, the coffee component comprises between about 4.745 grams to about 12.65 grams, the saccharide component comprises between about 6.3 grams to about 19 grams, the ginseng component comprises between about 0.1 grams to about 0.6 grams, and the protein component comprises between about 2.37 grams to about 42.745 grams.
... |
| Compositions to reduce blood glucose levels and treat diabetes | 20090169648 | 20090702 |
| The invention discloses compositions that effectively reduce and stabilize glucose levels in the blood of mammals, specifically in pre-diabetic patients and patients with type 2 diabetes mellitus (T2DM). Composition 1 (Comp1) reinforces efficacy of Mg salt to reduce glucose level by the combination of Mg salt with anti-inflammatory agents konjac-glucomannan (KGM), vitamin C and alpha-lipoic acid (α-LA). Composition 2 (Comp2) provides safety for chromium picolinate (CrPic) by the combination of CrPic with anti-inflammatory agents KGM, vitamin C and α-LA that inhibits oxygen radicals. Compositions may optionally include cinnamon extract (CE) or another insulinogenic nutraceutical agent, American ginseng (AG), Uncaria tomentosa, Uncaria guianensis and Urtica dioica.
... |
| Combination therapy for treatment of patients with neurological disorders and cerebral infarction | 20090162459 | 20090625 |
| The present invention provides compositions and methods of treating a patient having a condition selected from the group of cerebral stroke, heart stroke, neurodegenerative diseases, brain or nervous system trauma, or neuroplasticity wherein the composition comprises: (i) at least 4, 5, 6, 7, 8, 9, 10, 11, 12, 13 or 14 of: Radix Astragali (milkvetch root or Huang Qi); Rhizoma Salviae Miltiorrhizae root (red sage or Dan Shen); Radix Paeoniae Rubra (red peony or chi shao); Ligusticum Chuanxiong (Chuan Xiong); Rhizoma Notoginseng (Sanqi); Odoriferous Rosewood (Jiang Xiang); Scorpion (Quan Xie); Radix Polygalae (Yuan Zhi); Grassleaf sweetflag (Shi Changpu); Leech (Hirudo or Shuizhi); Ground beetle (Tu Bie Chong); Cow bezoar (calculus Bovis artifactus or Rengong Niuhuang); Gambirplant (ramulus uncariae cum uncis or Gou teng); and (ii) an... |
| Ginseng nutritious instant tea and preparation method thereof | 20090162523 | 20090625 |
| The present invention relates to a ginseng nutritious instant tea comprising water-soluble active ingredients. The raw materials thereof mainly comprise tea, chrysanthemum and ginseng with a ratio: ginseng 10 parts, tea 80-120 parts, preferably 100-110 parts, chrysanthemums 60-100 parts, preferably 70-80 parts. The said tea is green tea and black tea also can be used. According to personal taste, other raw materials and additives can be added, such as citric acid and sugar, etc. The preparation method for such instant tea is to select and formulate the major raw materials according to a certain proportion. The preparation mode is to firstly extract the water-soluble active ingredients from these raw materials in the water, then to filter and concentrate the water extract of all kinds of raw... |
| Combination therapy for treatment of patients with neurological disorders and cerebral infarction | 20090162459 | 20090625 |
| The present invention provides compositions and methods of treating a patient having a condition selected from the group of cerebral stroke, heart stroke, neurodegenerative diseases, brain or nervous system trauma, or neuroplasticity wherein the composition comprises: (i) at least 4, 5, 6, 7, 8, 9, 10, 11, 12, 13 or 14 of: Radix Astragali (milkvetch root or Huang Qi); Rhizoma Salviae Miltiorrhizae root (red sage or Dan Shen); Radix Paeoniae Rubra (red peony or chi shao); Ligusticum Chuanxiong (Chuan Xiong); Rhizoma Notoginseng (Sanqi); Odoriferous Rosewood (Jiang Xiang); Scorpion (Quan Xie); Radix Polygalae (Yuan Zhi); Grassleaf sweetflag (Shi Changpu); Leech (Hirudo or Shuizhi); Ground beetle (Tu Bie Chong); Cow bezoar (calculus Bovis artifactus or Rengong Niuhuang); Gambirplant (ramulus uncariae cum uncis or Gou teng); and (ii) an... |
| Ginseng nutritious instant tea and preparation method thereof | 20090162523 | 20090625 |
| The present invention relates to a ginseng nutritious instant tea comprising water-soluble active ingredients. The raw materials thereof mainly comprise tea, chrysanthemum and ginseng with a ratio: ginseng 10 parts, tea 80-120 parts, preferably 100-110 parts, chrysanthemums 60-100 parts, preferably 70-80 parts. The said tea is green tea and black tea also can be used. According to personal taste, other raw materials and additives can be added, such as citric acid and sugar, etc. The preparation method for such instant tea is to select and formulate the major raw materials according to a certain proportion. The preparation mode is to firstly extract the water-soluble active ingredients from these raw materials in the water, then to filter and concentrate the water extract of all kinds of raw... |
| Traditional chinese medicine composition to treat rheumatoid arthritis and preparation method thereof | 20090148536 | 20090611 |
| The present invention discloses a traditional Chinese medicine composition to treat Rheumatoid Arthritis and its preparation method. The composition is mainly comprised of the following crude drugs: ant, Radix Salviae Miltiorrhizae, Radix Aconiti Preparata, Radix Ginseng, Caulis Spatholobi, and Ramulus Cinnamomi, etc. According to pharmaceutical methods, various clinical acceptable dosage forms can be prepared of the composition of the present invention, including but not limited to one of the following dosage forms: tablets, capsules, pills, granules, suspension, dripping pills, oral liquid preparation, etc. The drug of the present invention has the functions of invigorating the kidney and spleen, promoting blood flow and clearing out the vein, expelling wind-evil and removing wetness, eliminating cold to stop pain. It can be effectively used in the treatment of lingering... |
| Medicine to treat drug addiction and preparation method thereof | 20090123559 | 20090514 |
| The present invention declares a pharmaceutical extract, composition that has effect to treat drug addiction, and its preparation method and quality control method. This extract is extracted from Radix Stephaniae Epigaeae. Starting medicine material of said composition is Radix Ginseng, Radix Astragali, Rhizoma Corydalis, Radix Angelicae Sinensis and Radix Ophiopogonis; and said composition also can prepared by ethanol extract of Radix Ginseng, ethanol extract of Radix Angelicae Sinensis, total alkaloids of Radix Stephaniae Epigaeae, water extract of Radix Astragali and water extract of Radix Ophiopogonis. Quality control method of said pharmaceutical composition includes one of or several of identifications and content determinations. The present invention also declares the use of said pharmaceutical extract, composition in the preparation of a medicine to treat drug addiction.
... |
| Method of making a black-ginseng and a condensed black-ginseng and a black-ginseng preserved in honey | 20090104323 | 20090423 |
| Disclosed are methods for manufacturing black ginseng, black ginseng extracts, and honey-soaked black ginseng confectionary, featuring conducting nine rounds of a maturing process subsequent to a steaming process, without a drying process therebetween. The black ginseng products can be commercially favorable commodities competing with conventional ginseng and red ginseng products, and have an excellent taste and flavor for persons of all ages all over the world, in addition to being healthful for the body.
... |
| Promoter for the production of hyaluronic acid containing ginsenoside compound k | 20090062217 | 20090305 |
| There are provided a promoter containing ginsenoside compound K for the production of hyaluronic acid, and more particularly, a new efficacy of 20-O-β-D-glucopyranosyl-20(S)-protopanaxadiol (compound K), a chief metabolite of ginseng saponin, to increase the expression of hyaluronic acid synthase gene in human cell and thereby to promote the production of hyaluronic acid, and an anti-aging agent containing the promoter for the production of hyaluronic acid as an effective ingredient.
... |
| Food composition with therapeutic agents | 20090047405 | 20090219 |
| Food compositions with therapeutic agents are described. The food compositions comprise oligosaccharides and/or polysaccharides that are fractions recovered from North American Ginseng. The food compositions can be tea beverages that have improved taste characteristics and that can provide enhanced immunity when consumed.
... |
| Compositions for correcting age related changes of a human endocrine system and methods for producing a pharmaceutical form bases on said compositions | 20090011041 | 20090108 |
| The present invention relates to anti-aging pharmacology and is intended for correction of age-related changes in human endocrine system. The essence of the invention is the compositions for correction of certain age-related endocrine changes and method for production of pharmaceutical form based thereon. Each composition contains a mixture of substances exhibiting hormonal activity (HA) or hormone-like activity (HLA) selected from the group: C21 or C19 steroids, pregnenolone, 17-hydroxypregnenolone, DHEA, progesterone, testosterone, or a hormone-like substance of herbal origin (HS), and also a dry methanolic of Nettle root extract, taken in a definite ratio, wherein HA, HLA or HS with the Nettle root extract can further contain a Deer Antler velvet extract and/or Ginseng root extract, and HS can comprise diosgenin or protodioscin. One variant of the... |
| Method of deleting nef gene in hiv-1 using red ginseng | 20090011053 | 20090108 |
| A method for inducing defective nef genes in HIV-1 using red ginseng is provided. More particularly, the present invention provides a method for inducing defective nef genes in HIV-1, which comprises administering an effective amount of red ginseng to a subject in need thereof. This method can derive gross deletion from the nef genes in HIV-1 and can thus be effectively applied in the prevention and treatment of AIDS.
... |
| Plant-based formulations for improving liver health | 20090011054 | 20090108 |
| The present invention is directed to plant based formulations for improving liver health by protecting the liver from alcohol and chemical insults and/or by inducing phase II enzymes. Formulations according to the present invention include wasabi root fiber powder, artichoke leaf extract, asparagus dehydrate, kudzu root extract, oregano extract, schisandra berry extract, notoginseng (ethanol extract of Panax notoginseng root), sanchi (water extracts from Panax notoginseng root), Gegen root extract (Pueraria omeiensis), spinach dehydrate, or combinations thereof.
... |
| Composition comprising ginsenosides for treating or preventing angiostenosis and restenosis | 20080311169 | 20081218 |
| The present invention relates to use of ginsenoside Rg3, Rg5 or Rk1, or extract of ginseng, red ginseng or processed ginseng comprising the ginsenosides; a composition for preventing or treating angiostenosis and restenosis comprising the ginsenosides or extracts; a method for preventing or treating angiostenosis and restenosis by administrating the ginsenosides or extracts comprising the ginsenosides; and a preparation method of agents for preventing or treating angiostenosis and restenosis. The present composition can effectively prevent or treat angiostenosis and restenosis.
... |
| Antioxidant and fe2+ chelating properties of herbal extracts | 20080292733 | 20081127 |
| The present invention is directed to antioxidative and antiproliferative agents containing North American ginseng (proprietary extract HT1001) alone or in combination with Ginkgo biloba (GB), Saint John's Wort (SJW), ginkgolides, flavonoids, ginsenosides, hypericin, and/or hyperforin. The antioxidative and antiproliferative agents according to the present invention show significant inhibition of Fe2+-catalyzed lipid peroxidation and Fe2+ chelation activity, the ability to scavenge hydroxyl free radicals, the ability to reduce neuroblastoma cell numbers, and/or the ability to promote neurite outgrowth. These effects are consistent with the behavior of Fe2+ chelators and the variance in both type and magnitude of effects exerted by the chemical components suggests a synergistic mechanism of action.
... |
| Processes of making north american ginseng fractions, products containing them, and use as immunomodulators | 20080286389 | 20081120 |
| The invention is directed to chemical processes of preparing fractions form North American ginseng (Panax quinquefolium) and pharmaceutical compositions containing these fractions. The products of the present invention may be used to stimulate the production of cytokines and/or antibodies, or as therapeutics targeted at conditions characterized by low immunity, such as the common cold, influenza, chronic fatigue syndrome, AIDS and cancer.
... |
| Composition for treatment of cold and flu | 20080274215 | 20081106 |
| The present invention is a composition delivering therapeutically effective amounts of Andrographis Paniculata standardized to 5.6% of Andrographolide:Siberian Ginseng:American Ginseng:Vitamin C in a single dosage unit.
... |
| Method of physicochemically producing glycogen and glycogen obtained by the same | 20080262217 | 20081023 |
| A method of producing glycogen is provided. The method comprises the step of heat- and pressure-treating a sugar-containing material under acidic conditions. The sugar-containing material is a polysaccharide or an oligosaccharide. Alternatively, the sugar-containing material is a plant material selected from the group consisting of Panax notoginseng, Yun Nan San-chi powder (trademark), Panax ginseng, wheat flour, soybean, soy flour, shiitake, and coffee extract residue. Representatively, the glycogen includes a molecule having a molecular weight of 10,000 or less. The glycogen has a specific rotation of [α]D+197° and anomeric proton peaks at 5.37 ppm and 4.95 to 5.33 ppm in 1H NMR spectra.
... |
| Composition comprising notoginseng radix extract for preventing and treating of arthritis as an effective ingredient | 20080233217 | 20080925 |
| Notoginseng radix extract of the present invention inhibits release of tumor necrosis factor-alpha (TNF-α) and is the death of activated T-cells only, so that it can be effectively used for the production of a medicine for preventing and treating arthritis and health food as well.
... |
| Medical composition containing ginseng secondary glycosides, its preparation method and application | 20080234208 | 20080925 |
| Medicinal composition containing ginseng secondary glycosides, its preparation method and application. The present composition contains mainly, as active ingredients, the ginsenoside with protopanoxadiol as aglucone (ginsenoside Rg3) and the ginsenoside with protopanoxatriol as aglucone (ginsenoside Rg2 and ginsenoside Rh1). It is prepared from the ginseng genus of plants through extracting, acid hydrolyzing and using macroreticular resin to separate, purify and concentrate. It is useful in the manufacture of medicaments for treating CHD, angina pectoris, myocardial ischemia, hemorrhagic shock, heart failure, and arrhythmia.
... |
| Method of extracting ginsengnoside rg2m, pharmaceutical composition including ginsengnoside rg2, and uses thereof | 20080227760 | 20080918 |
| The present invention provides a method of extracting ginsenoside Rg2, which is applied to mass production. The method of the present invention employs gradient salting-out instead of conventional silica gel chromatography, and therefore enables convenient performance and mass production of ginsenoside Rg2. Provided are also a pharmaceutical composition comprising ginsenoside Rg2 as an active ingredient, and prophylactic and therapeutic agents for preventing and treating dementia, depression, peripheral circulation disorder and related diseases, utilizing the pharmaceutical composition.
... |
| Fermented panax notoginseng solution with anti-cancer effects and manufacture method thereof | 20080220100 | 20080911 |
| This invention relates to a fermented Panax notoginseng solution and manufactured method thereof. The manufacture method comprises activating a Lactobacillus spp, fermenting a Panax notoginseng medium with the Lactobacillus spp. to form a fermented solution, and centrifuging the fermented solution to obtain a supernatant. The supernatant has anti-cancer effects.
... |
| Method for preparing micron-sized ginseng powder via mechanical grinding | 20080210789 | 20080904 |
| Disclosed is a method for preparing micron-sized ginseng powder via mechanical grinding, the method comprising the steps of: grinding ginseng roots crudely in order to facilitate micro-pulverization of ginseng, grinding the crude ginseng powder finely, and further grinding the ginseng powder ultra-finely. The ginseng micropowder obtained from the method has a maximum particle diameter of 40 μm or less, an average particle diameter of less than 8 μm and a uniform particle size, and thus shows excellent dispersibility, miscibility and absorptiveness. Therefore, the micropowder can be used for manufacturing various health-aid foods or medicines such as drinks, tablets or capsules and cosmetic products such as functional skin care agents or skin packs.
... |
| Anti-resorptive and bone building dietary supplements and methods of use | 20080199545 | 20080821 |
| Disclosed herein are dietary supplement compositions and methods for increasing or stimulating bone growth, decreasing or preventing bone resorption, increasing bone strength, improving bone structure, and improving bone architecture comprising a first composition comprising a combination of at least two of: quercetin, Rehmannia sp., Rehmannia sp. root, Siberian ginseng, Sophora japonica, licorice, and ipriflavone, wherein the combination of the first composition increases bone morphogenic protein-2 gene, promoter or protein expression; and a second composition comprising an extract of pomegranate in combination with at least one of Siberian ginseng, Ginkgo biloba, green tea, Sophora japonica, Rehmannia sp., grape seed, Dong Quai, and ipriflavone, wherein the combination of the second composition inhibits the expression of RANK-L.
... |
| Anti-resorptive and bone building dietary supplements and methods of use | 20080199546 | 20080821 |
| Disclosed herein are dietary supplement compositions and methods for increasing or stimulating bone growth and, decreasing or preventing bone resorption comprising a first composition comprising a combination of at least two of: quercetin, Rehmannia sp., Rehmannia sp. root, Siberian ginseng, Sophora japonica, licorice, and ipriflavone, wherein the combination of the first composition increases BMP-2 gene expression, promoter activity, or protein expression; and a second composition comprising an extract of pomegranate in combination with at least one of Siberian ginseng, Ginkgo biloba, green tea, Sophora japonica, Rehmannia sp., grape seed, Dong Quai, and ipriflavone, wherein the combination of the second composition inhibits the expression of RANK-L.
... |
| Method for preparing alcoholic beverage using incubated wild ginseng root | 20080193592 | 20080814 |
| The present invention relates to a method of preparing alcoholic beverages using incubated wild ginseng root. Specifically, the present invention relates to a method of preparing alcoholic beverages comprising incubated wild ginseng root, characterized in that it comprises a step of introducing the incubated wild ginseng root in an amount of 0.5-5 wt % during bottling process, followed by capping, and alcoholic beverages comprising incubated wild ginseng root which is produced by said method.
... |
| Analytical methods for identifying ginseng varieties | 20080175929 | 20080724 |
| An analytical method for identifying woods-grown ginseng and mountain cultivated ginseng comprise: (a) preparing ginseng extracts, (b) acquiring fingerprint regions by GC-MS analysis, (c) selecting at least 8 GC peaks for similarity calculation; (d) calculating similarity coefficients; and (e) comparing similarity coefficients of samples to those of standards.
... |
| Method for administering appetite suppressant and composition thereof | 20080138447 | 20080612 |
| A composition, which includes Guarana extract 36%, Hoodia 20:1, Cha de bugre 4:1, Ginseng, Citrus Auratium, Magnolia bark extract, and black pepper, for suppressing appetite as well as a method for the weight reduction of a body by administering a dosage of the composition, are disclosed. The composition, which is preferably a 575 mg dosage, contains an amount of Guarana extract 36% within the range of from about 40% to about 70% by weight. The composition contains an amount of Hoodia 20:1 within the range of from about 12% to about 30% by weight. The composition contains an amount of Cha de bugre 4:1 within the range of from about 5% to about 25% by weight. The composition contains an amount of Ginseng within the range... |
| Composition comprising the extract of crude drug complex having neuroprotective activity for preventing and treating stroke and neurodegenerative diseases | 20080131530 | 20080605 |
| The present invention relates to a composition comprising an extract of crude drug complex comprising Panax ginseng C. A. Meyer, Acanthopanax senticosus HARMS, Angelica sinensis DIELS, Scutellaria baicalensis GEORGI, prevention and treatment of stroke and neurodegenerative diseases such apoplexy, Alzheimer's disease (AD), Parkinson's disease (PD), Pick's disease, Creutzfeldt-Jakob disease and senile dementia.
... |
| Konjac mannan and ginseng compositions and methods and uses thereof | 20080131531 | 20080605 |
| Described are a number of compositions, namely a konjac mannan mixture, a ginseng composition, and a composition comprising konjac mannan and American ginseng. Methods of use of these compositions are described including their use for reducing blood glucose in non-diabetic and diabetic individuals, as well as reducing postprandial blood glucose in such individuals. Applications in the treatment of hyperlipidemia, high blood pressure, an increase in nitric oxide, Syndrome X and cardiovascular disease are also described. Various other applications of the compositions and methods are also described.
... |
| Method for producing ginseng fruit and ginseng flower stalk with high content of ginsenoside | 20080113043 | 20080515 |
| Disclosed is a method for producing ginseng fruits and flower stalks with high content of ginsenoside. More particularly, the present invention provides a method for producing ginseng fruits and flower stalks with high contents of ginsenoside Rb1, ginsenoside Rb2, ginsenoside Rc, ginsenoside Rd, ginsenoside Re and other ginsenoside ingredients. According to the present invention, the ginseng fruits and flower stalks have considerably increased contents of ginsenoside Re, Rd and Rb2 compared with general red ginseng roots and/or black ginseng roots. In addition, the present invention can provide ginseng fruits and flower stalks based products with high contents of, especially, ginsenoside Rb1, ginsenoside Rb2, ginsenoside Rc, ginsenoside Rd and/or ginsenoside Re by processing the fruits and flower stalks.
... |
| Medical herb composition for the alleviation of cardiopulmonary ailments or the improvement of cardiopulmonary function in a mammal | 20080063734 | 20080313 |
| A medical herb composition for the alleviation of cardiopulmonary ailments or the improvement of cardiopulmonary function in a mammal is disclosed. The medical herb composition comprises: Schisandra extract; Ginseng extract; Radix ophiopogonis extract; and Saliva miltiorrhiza extract. The medical herb composition comprising the extracts above is proved to be efficient in enhancing cardiopulmonary function of a mammalian patient without heart disease, enforcing energy and raising strength. The medical herb composition is also capable of reducing the symptoms of breathing difficulties and stagnation of vital energy.
... |
| Method for preparing extract from wild ginseng showing anticancer activity and the composition comprising the same | 20080050426 | 20080228 |
| The present invention relates to a method for preparing purified extract from wild ginseng showing anticancer activity such as inhibitory of cancer cell adherence, inhibitory of cancer cell metastasis and immunostimulating effect and a composition comprising the same prepared by inventive method. The composition have potent anticancer activity, therefore, it can be used as the therapeutics for treating and preventing various cancer diseases.
... |
| Composition containing ginsenoside f1 or compound k for skin external application | 20080045467 | 20080221 |
| The present invention relates to an inhibitor for the biosynthesis of gelatinase comprising ginsenoside F1 (20-O-β-D-glucopyranosyl-20(S)-protopanaxatriol) or compound K (20-0-β-D-glucopyranosyl-20(S)-protopanaxadiol), which is a chief metabolite of ginseng saponin, as an active ingredient; and a cosmetic/medical composition for the prevention of skin-aging comprising the same which is superior in inhibiting the decomposition of epidermal-dermal junction and also in accelerating the generation thereof.
... |
| Herbal mixture extract of pleurotus eryngii, acanthopanacis cortex and notoginseng radix and a composition comprising the same for prevention and treatment of periodontitis | 20080038212 | 20080214 |
| The present invention relates to a herbal mixture extract of Pleurotus eryngii, Acanthopanacis Cortex and Notoginseng Radix and a composition for prevention and treatment of periodontal disease containing the herbal mixture extract as an active ingredient, more precisely, a herbal mixture extract having activities of inhibiting the generation and activation of osteoclasts by enhancing the expression of osteoprotegerin (OPG) in osteoblasts, preventing alveolar bone from destruction by inhibiting the proliferation of osteoclasts and maintaining the growth of periodontal ligament cells and gingival fibroblasts, and a composition for prevention and treatment of periodontal disease containing the above mixture as an active ingredient.
... |
| Compositions and methods for promoting brain and cardiovascular health, preventing and treating brain and cardiovascular disorders | 20080031978 | 20080207 |
| Compositions, kits and methods are provided for promoting brain and cardiovascular health, preventing or treating neurological and vascular disorders. In one embodiment, the composition comprises Rhodiola rosea (root), Ginkgo biloba (leaf), Panax notoginseng (root), and Ligusticum chuanxiong (rhizome). The composition can be used as pharmaceuticals or nutraceuticals for promoting general brain health, maintaining a healthy brain, and all neurological disorders such as memory loss, ischemic stroke, neurodegenerative diseases (e.g., Huntington's disease, Alzheimers's disease, and amyotrophic lateral sclerosis) and vascular diseases such as arteriosclerosis, congestive heart failure, hypertension, cardiovascular diseases, cerebrovascular diseases, renovascular diseases, mesenteric vascular diseases, pulmonary vascular diseases, ocular vascular diseases, peripheral vascular diseases, peripheral ischemic diseases, and the like.
... |
| Brain cell- or nerve cell-protecting agents comprising medicinal ginseng | 20080020988 | 20080124 |
| The present invention provides medicinal or pharmaceutical compositions and preparations for administration, which are useful as cytoprotective agents and a remedy for neurotrauma, comprising ginseng, its extract, ginseng components, metabolites thereof or salts thereof (for example, red ginseng powder or components thereof). More particularly, the present invention provides medicinal or pharmaceutical compositions for inhibiting apoptosis or apoptosis-like cell death, medicinal or pharmaceutical compositions for promoting the expression of a cell death-suppressing gene product BCl-xL, or preparations for oral or intravenous administration, comprising ginseng, its extracts, ginseng components, metabolites thereof or salts thereof preferably at low concentrations. These medicinal or pharmaceutical compositions and/or preparations for administration are characterized by containing, as the active ingredient(s), ginseng, its extracts, ginseng components, metabolites thereof or salts thereof at low concentrations.... |
| Herbal mixture extract of notoginseng radix, rehmanniae radix preparata and acanthopanacis cortex and composition comprising the same for prevention and treatment of arthritis | 20070275103 | 20071129 |
| The present invention relates to a herbal mixture extract of Notoginseng radix, Rehmanniae radix preparata and Acanthopanacis cortex, and a composition for the prevention and the treatment of arthritis comprising the same as an effective ingredient. The herbal mixture extract of the present invention can be effectively used for the prevention and the treatment of arthritis because it inhibits the release of an inflammatory substance and the synthesis of cartilage destroying substance as well as the progress of arthritis.
... |
| Identification of ginseng and its imposters using genetic variations | 20070264638 | 20071115 |
| This invention provides methods, compounds, and kits for identifying ginseng (Panax) species and for distinguishing between ginseng and imposter species based upon molecular variations. In particular, amplification primers are provided that amplify polymorphic regions of nucleic acid sequences to generate distinct amplification profiles in the different plant species. A plant may be identified by comparing its amplification profile to known amplification profiles of Panax and imposter species.
... |
| Compositions to reduce blood glucose levels and treat diabetes | 20070254047 | 20071101 |
| The invention discloses compositions that effectively reduce and stabilize glucose levels in the blood of mammals, specifically in pre-diabetic patients and patients with type 2 diabetes mellitus (T2DM). Composition 1 (Comp1) reinforces efficacy of Mg salt to reduce glucose level by the combination of Mg salt with anti-inflammatory agents konjac-glucomannan (KGM), vitamin C and alpha-lipoic acid (α-LA). Composition 2 (Comp2) provides safety for chromium picolinate (CrPic) by the combination of CrPic with anti-inflammatory agents KGM, vitamin C and α-LA that inhibits oxygen radicals. Compositions may optionally include cinnamon extract (CE) or another insulinogenic nutraceutical agent, American ginseng (AG), Uncaria tomentosa, Uncaria guianensis and Urtica dioica.
... |
| Landscaping, plant potting, and horticulture methods according to the traditional oriental or korean medicine | 20070248695 | 20071025 |
| Plants that are substantially utilized as the medicinal ingredients in a selected single prescription of the traditional Oriental and Korean medicine are planted together in close proximity to each other. The plants provide therapeutic effects to the body of a person breathing the fragrance emitted by the plants and observing the plants. The plants are selected in accordance with the prescription of Sagunja-tang (a ginseng; a Atractylodes japonica koidz; a Glycyrrhiza uralensis Fisch; and a Pinus densiflora) or Samul-tang (an Angelica gigas Nakia; a Cnidium oficinale; a Paeonia lactiflora Pall; and a Rhemanniae glutinosa Libosch) or Palmul-tang (the eight plants selected according to Sagunja-tang and Samul-tang) or Shipjundaebo-tang (the eight plants according to Palmul-tang plus an Astrualus membranaceus Bunge var and a Cinnamon). These plants can... |
| Method for increasing content of physiologically active substance in ginseng | 20070224297 | 20070927 |
| The present invention relates to a method for economically preparing ginseng extract having an increased content of physiologically active substances, comprising the steps of steaming ginseng at 95 to 100° C. for 1 to 24 hours, collecting the generated vapor by cooling, and repeating the process twice, to a composition for promoting collagen synthesis, comprising the extract, and to a cosmetic product for improving skin wrinkles, comprising the composition.
... |
| Herbal compositions comprising portaluca | 20070184127 | 20070809 |
| The present invention relates to herbal compositions and their use in suppressing appetite, promoting body weight loss, stimulating thermogenesis, and/or treating mood disorders, such as anxiety or anger. An herbal composition of the present invention can comprise Portulaca oleracea, and optionally, Green tea, Lotus leaf, and/or Ginseng.
... |
| Ginseng composition for preventing or improving the lowering of concentration and memory capability | 20070184129 | 20070809 |
| The present invention relates to a ginseng composition equally comprising more than a certain amount of 10 kinds of ginsenoside in ginseng having particular pharmacological effect; or a composition for the prevention or improvement of lowering of concentration and memory capability comprising ginsenoside Rg3, Rg5 or RkI; a use thereof; a method for the prevention or improvement of lowering of concentration and memory capability by administrating the above composition; and a method for preparing agents for the prevention or improvement of lowering of concentration and memory capability by extracting ginseng etc. or mixing 10 kinds of ginsenoside in ginseng.
... |
| Stimulant-containing nutrition bar product and method of manufacture | 20070172542 | 20070726 |
| A stimulant-containing nutrition bar where the stimulant added to the bar exhibits a physical structure which is compatible with the manufacturing process used to prepare a nutrition bar. Simultaneously, the physical structure and the chemical composition of the stimulant reduces the amount of bitter taste which is experienced by a person eating the nutrition bar. Stimulants of the kind which are useful in the nutrition bar must be approved as food grade materials and are typically selected from the group consisting of caffeine, theobromine, green tea with high EGCG, taurine, ginseng, synephrine, and combinations thereof. The amount of stimulant present in the nutrition bar ranges from about 0.08% by weight to about 0.16% by weight of the nutrition bar.
... |
| Nutritional composition and method of manufacture | 20070141122 | 20070621 |
| A nutritional composition, and method of making it, that includes a carbohydrate, an insulin potentiator, an amino acid, a muscle growth stimulator, an energy increaser and at least one flavoring ingredient. The composition may be provided in dry form for addition to a fluid or in liquid forms. The composition is ingested to improve endurance and muscle tissue repair after exercise. In an embodiment the composition includes vanadyl sulfate, gamma oryzanol and American ginseng.
... |
| Plant-based formulations for improving liver health | 20070110831 | 20070517 |
| The present invention is directed to plant based formulations for improving liver health by protecting the liver from alcohol and chemical insults and/or by inducing phase II enzymes. Formulations according to the present invention include wasabi root fiber powder, artichoke leaf extract, asparagus dehydrate, kudzu root extract, oregano extract, schisandra berry extract, notoginseng (ethanol extract of Panax notoginseng root), sanchi (water extracts from Panax notoginseng root), Gegen root extract (Pueraria omeiensis), spinach dehydrate, or combinations thereof.
... |
| Ginseng wine | 20070087062 | 20070419 |
| The present application discloses a process for making ginseng wine.
... |
| Traditional chinese medicine preparation for cardio-cerebral blood vessel diseases and its preparing method | 20070071834 | 20070329 |
| The present invention discloses a traditional Chinese medicine preparation for cardio-cerebral blood vessel diseases, it is prepared through extracting danshen and Notoginseng by lye, precipitating with alcohol, concentrating, and adding other medicine and excipients. Then using the HAPLY-MS and HAPLY fingerprint Atlas to characterize its Physicochemical properties completely. Using the fingerprint Atlas analysis method of the present invention, the structure and comparative content of biologically active component can be known. Characterization of the physical chemical properties of danshen and Notoginseng of traditional Chinese medicine preparation with this way is better than other methods of the prior art.
... |
| Pharmaceutical composition for the treatment of cardiovascular and cerebrovascular diseases | 20070053999 | 20070308 |
| The present invention discloses a pharmaceutical composition for the treatment of cardiovascular and cerebrovascular diseases which comprises Radix Salviae Miltiorrhizae extract 5.0%-70.0%, Radix Notoginseng extract 10.0%-85.0%, Radix Astragali extract 5.0%-70.0%, and Bomeol or oil of Lignum Dalbergiae Odoriferae 1.0%-15.0%. The composition is active against cerebral ischemia and myocardial ischemia. The effects are superior to total phenic acid of Radix Salviae Miltiorrhizae or total saponin of Radix Notoginseng respectively, or the combination thereof. The composition of the invention can provide various kinds of preparations by the addition of various accessories. Thus the invention provides a more effective and convenient composition of TCM effective sections and its preparations.
... |
| Aromatase activating agent | 20070041996 | 20070222 |
| The present invention is directed to an aromatase activating agent containing a plant selected from among mulberry bark, ginseng, cucumber, and phellodendron bark; or chlorella; or an extract of any of these ingredients. The aromatase activating agent of the present invention is highly safe to the human body, and useful as a drug or cosmetic composition for prevention, amelioration, or treatment of various lesions caused by estrogen deficiency.
... |
| Compositions and methods for symptomatic relief | 20070041993 | 20070222 |
| An herbal formula provides symptomatic relief for various diseases and especially for patients diagnosed with AIDS/ARC. Particularly preferred formulae include at least part of at least four plants selected from the group consisting of Panax ginseng, Angelica sinensis, Astralagus membranaceus, Ligustrum lucidum, Sophora flavescens, Trichosanthes kirilowii, Agrimonia pilosa, Ganoderma lucidum, Rehmannia glutinosa, Cordiceps sinensis, Oldenlandia diffusea, Isatis spec., Polyporus umbellatus, Pogostemon cablin, Solanum nigrum, Atractylodis macrocephalae, Clematis spec., and Glycyrrhiza spec., and further include at least one of calculus bovis, concha pteriae powder, and borneolum syntheticum.
... |
| Supplemental dietary composition including caffeine, taurine and ginseng | 20070031568 | 20070208 |
| A dietary supplement and method for increasing energy and mental alertness of an individual, e.g. a human or an animal, is provided comprising at least Caffeine Anhydrous, Taurine, an extract of American Ginseng Root and extract of Green Tea leaf and tender shoots. Additionally, a method for increasing energy and mental alertness in an individual is also provided.
... |
| Composition comprising notoginseng radix extract for preventing and treating of arthritis as an effective ingredient | 20070014879 | 20070118 |
| Notoginseng radix extract of the present invention inhibits release of tumor necrosis factor-alpha (TNF-α) and is the death of activated T-cells only, so that it can be effectively used for the production of a medicine for preventing and treating arthritis and health food as well.
... |
| Personal care compositions and methods for the beautification of mammalian skin and hair | 20070009474 | 20070111 |
| Personal care composition comprising from about 0.05% to about 5% of at least one aquaporin-stimulating compound selected from the group consisting of xanthine, caffeine; 2-amino-6-methyl-mercaptopurine; 1-methyl xanthine; 2-aminopurine; theophylline; theobromine; adenine; adenosine; kinetin; p-chlorophenoxyacetic acid; 2,4-dichlorophenoxyacetic acid; indole-3-butyric acid; indole-3-acetic acid methyl ester; beta-naphthoxyacetic acid; 2,3,5-triiodobenzoic acid; adenine hemisulfate; n-benzyl-9-(2-tetrahydropyranyl)adenine; 1,3-diphenylurea; 1-phenyl-3-(1,2,3-thiadiazol-5-yl)urea; zeatin; indole-3-acetic acid; 6-benzylaminopurine; alpha-napthaleneacetic acid; 6-2-furoylaminopurine; green tea extract; white tea extract; menthol; tea tree oil; ginsenoside-RB1; ginsenoside-RB3; ginsenoside-RC; ginsenoside-RD; ginsenoside-RE; ginsenoside-RG1; ginseng root extract; ginseng flower extract; pomegranate extract, extracts from Ajuga turkestanica; extracts from viola tricolor and combinations thereof; an additional ingredient selected from the group consisting of niacinamide, glycerin and mixtures thereof, and a dermatologically-acceptable carrier.
... |
| Method for regulating nutrient absorption with ginsenosides | 20060293255 | 20061228 |
| There is provided a method for regulating the absorption of a nutrient in a subject, including administering to the subject an effective amount of a ginsenoside compound purified from Panax notoginseng for modulating transportation of the nutrient across gut cells of the subject.
... |
| Universal antioncotic and pain relieving ointment | 20060269569 | 20061130 |
| Described is a universal antioncotic and pain reducing ointment comprising an ointment formulated from the following herbs: Eucommiae Cortex, San-Chi Ginseng Radix, Radix Rehmanniac, Sparganii Rhizoma, Zedoariae Rhizoma, Angelicae Sinensis Radix, Radix Ledebouriellae, Sappan Lignum, Gardneiae Fructus, Salviae Radix, Olibanum (Gummi Olibanum), Myrrha, Lonicerae Flos, Ginseng Radix Rubra, and panacis Quinquefolii Radix
... |
| Herbal composition and method of use for promoting erections and treating erectile dysfunction in men | 20060269623 | 20061130 |
| This invention is directed toward herbal compositions and methods of treatment for prevention or treatment of erectile dysfunction disorders and ameliorating symptoms thereof and as a preventative measure against erectile dysfunction. The methods comprise administering a therapeutically effective composition of matter comprising the following herbal and other components: Herba cynomorii, Rhizhomnas atractylodis macrocephalae, Radix rehmannia glutinosea longui, Herba epimedii, Fructus lycii, Fructus schisandrae chinensis, Radix poloygoni multiflor, Cortex cinnamonia cassiae, Fructus amoni, and Radix ginseng. The components of the invention interact synergistically once consumed to remedy or prevent erectile dysfunction when taken as prescribed. The invention is completely herbal in composition and does not contain any hormones, morphine, or any of the compositions of matter know by trade names Viagra, Cialis, Sildenafil or Vardenafil. Side benefits... |
| Pharmaceutical composition for treatment of emiction disorders caused by benign prostate hyperplasia (bph) and the method | 20060263457 | 20061123 |
| A pharmaceutical composition with higher curative effect on benign prostate hyperplasia and emiction disorders is disclosed. It uses plants such as ginseng and gingko as well as cassia twig, cinnamon and liquorices both for food and medicine as raw materials. These raw materials are decocted or extracted separately in ethanol solution or water, then concentrated and dried to make the said pharmaceutical composition. Because this pharmaceutical composition is not toxic and has no side effect, it can be prepared as a medicament and healthy food to treat and improve benign prostate hyperplasia and emiction disorders caused by benign prostate hyperplasia.
... |
| Complementary compositions to reduce blood glucose levels and treat diabetes | 20060251736 | 20061109 |
| The invention discloses serial administration of two complementary compositions that effectively reduce and stabilize glucose levels in the blood of mammals, specifically in pre-diabetic patients and patients with type 2 diabetes mellitus (T2DM). The first composition (Comp1) comprises (−)-hydroxycitric acid ((−)-HCA), magnesium salt (Mg) and konjac mannan (KM). The second composition (Comp2) comprises chromium picolinate (CrPic), magnesium salt (Mg) and alpha-lipoic acid (α-LA). The second composition optionally may include one or more of Comp1, cinnamon extract (CE) and American ginseng (AG).
... |
| Medicament containing epimedium extract for treatment of prostatic hyperplasia and prostatitis | 20060246164 | 20061102 |
| This present invention relates to a method for extracting Epimedium herb to prepare flavones and polysaccharides combinations in which their ratios vary from 2:8 to 8:2 by weight and applying these extracted compositions in treatment of prostatic hyperplasia. Total flavones of the extracts are in the range of 20-90% and the molecular weights of extracted polysaccharides vary from 1,000 to 700,000 Daltons. This invention also includes a method for preparing compounded formulations which contain extracts of Radix Ginseng, pollens, Radix Astragali, Cortex Phellodendri, Epimedium flavones and polysaccharides and administering these compositions directed at treatment of prostatic hyperplasia and prostatitis. Clinical study has showed that these extracts and formulations are effective in treatment of prostate illness with no adverse reactions.
... |
| Novel method for preparing processed ginseng to obtain increased amount of ginsenoside rg5 | 20060228430 | 20061012 |
| The present invention relates to a processing method for preparing pharmacologically potent ginseng product and the extract therefrom which could provide abundant amount ginsenoside Rg5 showing various pharmacological activities with applying selected range of pressure and temperature into the method and therefore the composition comprising the processed ginseng and the extract thereof can be useful as a medicament or health care food in the prevention or treatment of various diseases, especially, cancer disease.
... |
| Nanoemulsion comprising metabolites of ginseng saponin as an active component and a method for preparing the same, and a skin-care composition for anti-aging containing the same | 20060216261 | 20060928 |
| Disclosed herein is nanoemulsion prepared by emulsifying main metabolites of ginseng saponin obtained by conversion of glucose, i.e. compound K (20-O-β-D-glucopyranosyl-20(S)-protopanaxadiol), ginsenoside F1 (20-O-β-D-glucopyranosyl-20(S)-protopanaxatriol) and compound Y (20-O-[α-L-arabinopyranosyl(1→6)-β-D-glucopyranosyl]-20(S)-protopanaxadiol); and admixture-thereof, in fine emulsion or liposome with dermotropic emulsifier by nano-emulsification; and having enhanced skin penetration, so to be effective in promoting proliferation of fibroblast and biosynthesis of collagen.
... |
| Supplemental dietary composition for promoting weight loss | 20060210650 | 20060921 |
| Compositions, and methods for administering the same to humans, are provided for the promotion of healthy fast weight loss while providing an excellent source of calcium and containing antioxidants. The compositions preferably comprise three sources of calcium and include at least one of Calcium Carbonate, Vitamin D, caffeine-free Green Tea, Garcinia Cambogia Extract, Gymnema Sylvestre Extract, Ginseng, Grape Skin Extract, Chromium Polynicotinate, and Policosanol. The supplemental dietary composition may be suitable for individuals on a calorie-restricted diet and exercise program.
... |
| Ginseng preparation using vinegar and process for thereof | 20060198908 | 20060907 |
| The present invention relates to a ginseng preparation using vinegar and a process for preparing the same, more particularly to a ginseng preparation comprising high concentrations of ginsenosides (Rg3, Rg5, and Rh1), which are generated by heat and exist only small amounts in red ginseng comprising various organic acids of vinegar, including citric acid, which is prepared by adding vinegar of pH 2 to 4 to ginseng, heat-extracting the same for 0.5 to 24 hours, and a method for preparing the ginseng preparation.
... |
| Herbal compositions | 20060159725 | 20060720 |
| A composition containing extracts obtained form Fructus Crataegi, Semen Zizyphus, Fructus Schizandrae, and Panax Ginseng. Also disclosed is a method of treating cancer or modulating an immune response in a subject and a method of inducing a cytokine in a cell with the composition.
... |
| Promoter for the production of hyaluronic acid containing ginsenoside compound k | 20060160752 | 20060720 |
| There are provided a promoter containing ginsenoside compound K for the production of hyaluronic acid, and more particularly, a new efficacy of 20-O-β-D-glucopyranosyl-20(S)-protopanaxadiol (compound K), a chief metabolite of ginseng saponin, to increase the expression of hyaluronic acid synthase gene in human cell and thereby to promote the production of hyaluronic acid, and an anti-aging agent containing the promoter for the production of hyaluronic acid as an effective ingredient.
... |
| Notoginseng saponin intravenous injection and the method for preparing this injection | 20060141070 | 20060629 |
| The invention shows the saponins family of Radix notoginshen intravenous injection, a method for preparation thereof. The object is to provide an intravenous injection for prevention and treatment of cardiac and cerebral vascular disease and its sequelae. This injection has stable pH, could be used in large dosage, and with main active component of saponins family of Radix notoginshen. The main components for this injection includes saponins family of Radix notoginshen with a concentration of 0.1 mg-14.0 mg (Rgl), iso-osmotic solution with a concentration of 7.5-9.6 mg/ml, and pH stabilizer with a concentration of 0.2-0.5 mg/ml. The solvent for said injection is distilled water. The method for preparation of the saponins family of Radix notoginshen intravenous injection includes: (1) dissolution of iso-osmotic solution in distilled water... |
| Ginseng fermented by lactic acid bacterium, yoghurt containing the same, and lactic acid bacteria used in the preparation thereof | 20060127379 | 20060615 |
| This invention relates to lactic fermenting products of ginseng obtained by fermentation of ginseng using lactic acid bacteria, yoghurt containing said lactic fermenting products of ginseng, and lactic acid bacteria used in the preparation of said lactic fermenting products of ginseng.
... |
| Comprehensive virus disinfecting strategy and methods for making a preventive anti-virus medical product | 20060127917 | 20060615 |
| The present invention provides a comprehensive virus disinfecting strategy with more than two biologically active anti-virus components work synergistically to form a multi-hurdle defending line for virus disinfecting, and methods for making a medical product with anti-virus properties. The comprehensive preventive system for virus disinfecting, combines components competitively inhibiting virus attachment on cell surface, immune-boosting nutrients for strengthening immunology defense, and components defectively attacking virus infusion process. The product is an anti-influenza medical food containing from 0.01% to 3% of glycopeptide with covalently attached sialic acids and its derivatives, 0.01% to 5% of ginseng extracts, and 0.01% to 3% of polyphonies from herb extracts. The anti-influenza medical product can be administrated daily to prevent from infection with viruses.
... |
| Galenical composition | 20060105061 | 20060518 |
| A method for preventing metal-induced oxidative damage of hepatocytes, for inhibiting hepatocellular carcinogenesis, or for increasing carcinogen-metabolizing enzyme activity, which comprises administering to a subject an effective amount of an extract of a galenical composition comprising Panax pseudoginseng, Eucommiae ulmoides and Polygonati Rhizoma as essential components.
... |
| Medicament containing epidemium extract for treatment of prostatic hyperplasia and prostatitis | 20060105067 | 20060518 |
| This present invention relates to a method for extracting Epimedium herb to prepare flavones and polysaccharides combinations in which their ratios vary from 2:8 to 8:2 by weight and applying these extracted compositions in treatment of prostatic hyperplasia. Total flavones of the extracts are in the range of 20-90% and the molecular weights of extracted polysaccharides vary from 1,000 to 700,000 Daltons. This invention also includes a method for preparing compounded formulations which contain extracts of Radix Ginseng, pollens, Radix Astragali, Cortex Phellodendri, Epimedium flavones and polysaccharides and administering these compositions directed at treatment of prostatic hyperplasia and prostatitis. Clinical study has showed that these extracts and formulations are effective in treatment of prostate illness with no adverse reactions.
... |
